Wisconsin Legislature: Drugs

Human trafficking: commercial driver education courses must include instruction on recognizing and preventing - AB540

Human trafficking: commercial driver education courses must include instruction on recognizing and preventing - SB444

Addiction medicine consultation program: DHS to create and administer - Jr7 AB9

Addiction medicine consultation program: DHS to create and administer - Jr7 SB9

Administration of prescription drugs to prisoners by correctional officers prohibited unless certain conditions are met; report required - AB707

Administration of prescription drugs to prisoners by correctional officers prohibited unless certain conditions are met; report required - SB595

Biological products: pharmacy laws revised re prescribing and dispensing, interchangeable biological product provision - AB679

Biological products: pharmacy laws revised re prescribing and dispensing, interchangeable biological product provision - SB575

Controlled substance abuse screening, testing, and treatment requirements for applicants of WEDC economic development programs - AB385

Cost reporting by manufacturers of brand-name and generic drugs: requirements created; DHS and OCI duties and penalty provision - AB620

Cost reporting by manufacturers of brand-name and generic drugs: requirements created; DHS and OCI duties and penalty provision - SB531

Covered prescription drug or device: health insurance policy or plan prohibited from denying coverage during a policy or plan year if it was covered when the insured enrolled or renewed - AB622

Covered prescription drug or device: health insurance policy or plan prohibited from denying coverage during a policy or plan year if it was covered when the insured enrolled or renewed - SB530

Dextromethorphan in drugs: sales to minors without a prescription prohibited; ID and penalty provisions - AB681

Dextromethorphan in drugs: sales to minors without a prescription prohibited; ID and penalty provisions - SB587

Dispensing, distributing, or selling dialysate, drugs, or devices necessary for providing home peritoneal kidney dialysis to patient with end-stage renal disease: exemption from pharmacist license requirement, conditions set - AB1047

Dispensing, distributing, or selling dialysate, drugs, or devices necessary for providing home peritoneal kidney dialysis to patient with end-stage renal disease: exemption from pharmacist license requirement, conditions set - SB875

Emergency administration of opioid antagonist to pupils and other persons appearing to overdose: civil liability for school bus operator and employees and volunteers of public, private, and tribal schools; calling 911 provision [A.Amdt.1: college residence hall director added] - Jr7 AB1

Emergency administration of opioid antagonist to pupils and other persons appearing to overdose: civil liability for school bus operator and employees and volunteers of public, private, and tribal schools; calling 911 provision - Jr7 SB1

Epinephrine auto-injectors: use and supply of by authorized individuals allowed; definition provision - AB96

Epinephrine auto-injectors: use and supply of by authorized individuals allowed; definition provision - SB209

Hospice worker authorization to transfer controlled substances of deceased person to drug disposal program established - AB444

Hospice worker authorization to transfer controlled substances of deceased person to drug disposal program established - SB361

Investigational drugs, devices, and biological products: access to by eligible patients and limitation of liability provisions - AB69

Investigational drugs, devices, and biological products: access to by eligible patients and limitation of liability provisions [S.Sub.Amdt.1: further revisions] - SB84

Medication for the purpose of ending life: individuals meeting requirements may request from their physicians; DHS duties; does not constitute attempted suicide - AB216

Medication for the purpose of ending life: individuals meeting requirements may request from their physicians; DHS duties; does not constitute attempted suicide - SB312

Off-patent or generic drug: price gouging by manufacturer or wholesale distributor prohibited; AG authority provision - AB1046

Off-patent or generic drug: price gouging by manufacturer or wholesale distributor prohibited; AG authority provision - SB874

Opioid treatment programs in underserved and high-need areas: DHS to create additional programs, funding provision [A.Amdt.4: methamphetamine treatment added] - Jr7 AB8

Opioid treatment programs in underserved and high-need areas: DHS to create additional programs, funding provision - Jr7 SB8

Prescription drug assistance for elderly program: waiver of federal Medicaid law required and use of excess GPR and PR moneys - AB55

Prescription drug assistance for elderly program: waiver of federal Medicaid law required and use of excess GPR and PR moneys - SB8

Prescription drug monitoring program clarification re review of patient records [A.Sub.Amdt.1: Sec. 2251c-x] - AB64

Prescription drug or device: health insurance policy prohibited from including provision prohibiting pharmacist from disclosing costs or availability of alternatives - AB800

Prescription drug or device: health insurance policy prohibited from including provision prohibiting pharmacist from disclosing costs or availability of alternatives - SB669

Prescription drug order extension when refill authorization cannot be obtained: pharmacist may dispense a limited supply under set conditions - AB125

Prescription drug order extension when refill authorization cannot be obtained: pharmacist may dispense a limited supply under set conditions - SB116

Prescription drugs exempt from the Unfair Sales Act - SB50

Prescription eye drops: health insurance policies required to cover refills - AB876

Prescription eye drops: health insurance policies required to cover refills - SB771

Prescription medication distributed by certain medical personnel only in a juvenile correctional facility or secured residential care center for children and youth; exception for insulin - AB467

Prescription medication distributed by certain medical personnel only in a juvenile correctional facility or secured residential care center for children and youth; exception for insulin - SB377

Pseudoephedrine product sales: implementation of electronic system for recording, tracking, and blocking illegal sales; National Precursor Log Exchange (NPLEx) and DOJ provisions - AB306

Pseudoephedrine product sales: implementation of electronic system for recording, tracking, and blocking illegal sales; National Precursor Log Exchange (NPLEx) and DOJ provisions - SB237

Schedule V controlled substances containing codeine may not be dispensed without a prescription - Jr7 AB4

Schedule V controlled substances containing codeine may not be dispensed without a prescription - Jr7 SB4

Spiritual treatment in lieu of medical or surgical treatment for children: exemptions removed re county department determination of child abuse or neglect, felony physical abuse of a child, and administration of psychotropic medication to juveniles in correctional custody; Christian Science treatment limited to adult patients - AB790

Substance abuse: continuing education for health care practitioners; federal waiver re dispensing narcotics for addiction treatment; prescribing and dispensing buprenorphine combination products; counseling changes re certification and who can offer treatment; school health instruction requirements; graduate program in psychiatric mental health nursing at UW—Madison; training resources for social service workers; DCF, DHS, and DSPS duties; administrative rules provisions [Admin.Code DHS 75.02, 75.03; MPSW 1.09; SPS 160 (title), 160.015, 160.02, 160.03, 161, 163.01, 163.02, 164.01, 165, 166, 168] [A.Amdt.1: MEB emergency rule provisions added, administrative rule provisions revised; A.Amdt.1 to A.Amdt.1: continuing education for certain health care providers provision deleted, MEB emergency rules and rule-making authority provisions deleted, adds reporting requirements for certain credentialing boards re opioids] - AB907

Substance abuse: continuing education for health care practitioners; federal waiver re dispensing narcotics for addiction treatment; prescribing and dispensing buprenorphine combination products; counseling changes re certification and who can offer treatment; school health instruction requirements; graduate program in psychiatric mental health nursing at UW—Madison; training resources for social service workers; DCF, DHS, and DSPS duties; administrative rules provisions [Admin.Code DHS 75.02, 75.03; MPSW 1.09; SPS 160 (title), 160.015, 160.02, 160.03, 161, 163.01, 163.02, 164.01, 165, 166, 168] - SB767

Third party logistics providers exempt from regulation as prescription drug wholesale distributors by the Pharmacy Examining Board; enforcement and disciplinary authority of DSPS and attached boards and credentialing boards modified; interest charged on costs of disciplinary proceedings provision - AB902

Third party logistics providers exempt from regulation as prescription drug wholesale distributors by the Pharmacy Examining Board; enforcement and disciplinary authority of DSPS and attached boards and credentialing boards modified; interest charged on costs of disciplinary proceedings provision - SB750

Unfair Sales Act: exception for prescription drugs and other merchandise; prohibition narrowed to specified products - AB359

Unfair Sales Act: exception for prescription drugs and other merchandise; prohibition narrowed to specified products - SB263

Advisory referendum on legal access to medical marijuana for individuals with debilitating medical conditions - AJR7

Advisory referendum on legal access to medical marijuana for individuals with debilitating medical conditions - SJR10

Aiding a person suffering from an overdose or adverse reaction and immunity from controlled substance prosecution: revisions to 2017 WisAct 33 re initial applicability clause, bail jumping immunity, and sunset the bail jumping changes [A.Sub.Amdt.1: Sec. 2251xg-xs, 2265r, 9452 (2x)] - AB64

Aiding a person suffering from an overdose or adverse reaction: immunity from prosecution for controlled substance possession or having probation, parole, or extended supervision revoked provisions created for the person being aided and the aider [A.Amdt.2: ``aider" definition revised] - Jr7 AB3

Aiding a person suffering from an overdose or adverse reaction: immunity from prosecution for controlled substance possession or having probation, parole, or extended supervision revoked provisions created for the person being aided and the aider - Jr7 SB3

Alternative sentencing for certain second or third OWI-related offenses and certain controlled substance offenses - AB1040

Cannabidiol (CBD oil) producers re treatment for medical condition: licensure program in DSPS established; possession and dispensing requirements modified - AB158

Cannabidiol (CBD oil) producers re treatment for medical condition: licensure program in DSPS established; possession and dispensing requirements modified - SB104

Crime labs, drug law enforcement surcharge, and DNA surcharge: revenue appropriation structure; Internet crimes against children provision [A.Sub.Amdt.1: Sec. 408c, f, p, t, v, 412h, 1673v, 2255p, 9228 (1p)] - AB64

Criminal investigation agent positions at DOJ authorized re drug interdiction and drug trafficking [A.Amdt.2: unencumbered moneys lapse to the general fund and used for alternatives to prosecution and incarceration programs, DOJ plan and JCF approval required] - Jr7 AB10

Criminal investigation agent positions at DOJ authorized re drug interdiction and drug trafficking - Jr7 SB10

DOJ to collect crime information from law enforcement agencies, DAs, and courts re firearms, marijuana, and motor vehicle thefts; quarterly compilations required - AB724

DOJ to collect crime information from law enforcement agencies, DAs, and courts re firearms, marijuana, and motor vehicle thefts; quarterly compilations required - SB611

Drug law enforcement activities: DOJ funding [A.Sub.Amdt.1: Sec. 9128 (1q)] - AB64

Drug trafficking, evidence-based substance abuse prevention, juvenile and family treatment courts, and drug treatment for inmates of county jails: grant programs established; DOJ, DHS, DCF duties [A.Amdt.1: ``juvenile" added to ``family treatment courts"; A.Amdt.2: tribal jail and law enforcement agency provisions added, search warrant based on sworn affidavit or complaint modified] - AB906

Drug trafficking, evidence-based substance abuse prevention, juvenile and family treatment courts, and drug treatment for inmates of county jails: grant programs established; DOJ, DHS, DCF duties - SB768

Employers prohibited from testing employees or prospective employees for marijuana or synthetic cannabinoids as a condition of employment, exceptions provision - AB1005

Fentanyl analogs added to Schedule I controlled substances, felony provisions [A.Sub.Amdt.1: further revisions; S.Amdt.1: adds chemical designations] - AB335

Fentanyl analogs added to Schedule I controlled substances, felony provisions - SB262

Industrial hemp: DATCP to issue licenses to grow and possess; agricultural pilot program to study; controlled substance law exemption; tribes, UW, testing, seed, and rules provisions - AB147

Industrial hemp: DATCP to issue licenses to grow and possess, criminal history search provision; agricultural pilot program to study; controlled substance law exemption; tribes, UW, testing, seed, and rules provisions - AB183

Industrial hemp: DATCP to issue licenses to grow and possess, criminal history search provision; agricultural pilot program to study; controlled substance law exemption; tribes, UW, testing, seed, and rules provisions [S.Sub.Amdt.1: further revisions, DATCP to regulate activities, UW and tribal authority provisions removed, penalty provisions added] - SB119

Marijuana: penalty for possession of not more than 10 grams reduced to a forfeiture - AB409

Marijuana: penalty for possession of not more than 10 grams reduced to a forfeiture - SB318

Marijuana use, medical and recreational, permitted with restrictions and excise tax and penalty provisions; DHS duties re medical marijuana registry, licensing compassion centers, and registering certain testing laboratories; permitted THC concentration while operating a vehicle revised; fair employment law, UI, and drug testing for specific public assistance and work experience programs exemption for THC; health insurance coverage required for medical use of tetrahydrocannabinols - AB482

Medical use of marijuana and marijuana distribution entities provisions created; DHS duties - AB75

Medical use of marijuana and marijuana distribution entities provisions created; DHS duties - SB38

Opioid treatment programs in underserved and high-need areas: DHS to create additional programs, funding provision [A.Amdt.4: methamphetamine treatment added] - Jr7 AB8

Pseudoephedrine products: purchase of more than set amount from a pharmacy or pharmacist in a 30-day period made a misdemeanor - AB764

Pseudoephedrine products: purchase of more than set amount from a pharmacy or pharmacist in a 30-day period made a misdemeanor - SB683